Lung Cancer Risk Rises With A1c, Falls With Medication
Researchers published the study covered in this summary on Preprints with The Lancet as a preprint that has not yet been peer reviewed.
Results from a large database study has shown a positive association between prediabetes, diabetes, and incident lung cancer.
Treatment with glucose-lowering medications was significantly linked with a reduced rate of incident lung cancer.
The relationship between incident lung cancer and A1c was nonlinear with the strongest associations occurring at A1c levels of 32-42 mmol/mol (5.1%-6.0%), levels that fall short of the cutoff for a diagnosis of diabetes, and at the lower end, fall short of the definition of prediabetes.
Wilt u de rest van dit artikel lezen?
Registreer gratis om toegang te krijgen tot de volledige inhoud van MediQuality op al uw schermen